Activation of receptor tyrosine kinases (RTKs), such as HER3, has been demonstrated to be a primary resistance mechanism in thyroid cancer cell lines following short-term culture (2–4 days) [13]. The gene discussed is NTRK1; the disease is thyroid cancer.